BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• Drug Development

  Vasogen’s VP025 Shown To Impact Inflammation-Signaling Pathways

  November 16, 2005

   · 

  5 min read
• Lone Star Bio

  Novartis Pharmaceuticals Corporation Release: NAVIGATOR Data Presented At American Heart Association’s Scientific Sessions Provide New Insights About Cardiovascular And Diabetes Risk

  November 16, 2005

   · 

  8 min read
• Business

  Isotechnika Inc. Announces Change In Executive Management

  November 16, 2005

   · 

  3 min read
• Drug Development

  ImmunoGen, Inc. Announces Presentation Of HuN901-DM1; Clinical Activity Reported Includes Sustained Complete Remission And Stable Disease

  November 16, 2005

   · 

  1 min read
• Drug Development

  New Data Shows Eli Lilly and Company’s ACTOS(R) (pioglitazone HCl) Reduced Heart Attacks By 28 Percent In People With Type 2 Diabetes

  November 16, 2005

   · 

  1 min read
• Drug Development

  Centocor, Inc. And Schering-Plough Corporation Next-Generation Biologic Shows Promise In The Treatment Of Rheumatoid Arthritis In Phase 2 Trial; Primary Endpoint Achieved

  November 16, 2005

   · 

  7 min read
• Business

  Biotel Inc. Announces Revenues And Earnings For The First Quarter Ended September 30, 2005

  November 16, 2005

   · 

  2 min read
• Drug Development

  Millennium Biotechnologies, Inc. Announces The Completion Of It’s Clinical Study Of Athletes Using Resurgex(R)

  November 16, 2005

   · 

  1 min read
• Drug Development

  ART Advanced Research Technologies Inc. Release: In Vivo Fluorescence Applications Using eXplore Optix For Pharmacokinetic Studies Presented At The In Vivo Molecular Imaging Conference In California

  November 16, 2005

   · 

  1 min read
• Drug Development

  ZIOPHARM, Inc. Oncology Announces ZIO-101 Phase I Data Presented At AACR-NCI-EORTC International Conference; Novel Organic Arsenic Evidences Both Safety And Activity

  November 16, 2005

   · 

  1 min read